G. B. Vogelsang

1.6k total citations
28 papers, 1.2k citations indexed

About

G. B. Vogelsang is a scholar working on Hematology, Oncology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, G. B. Vogelsang has authored 28 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Hematology, 8 papers in Oncology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in G. B. Vogelsang's work include Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (6 papers) and Multiple Myeloma Research and Treatments (4 papers). G. B. Vogelsang is often cited by papers focused on Hematopoietic Stem Cell Transplantation (20 papers), Acute Myeloid Leukemia Research (6 papers) and Multiple Myeloma Research and Treatments (4 papers). G. B. Vogelsang collaborates with scholars based in United States, France and Germany. G. B. Vogelsang's co-authors include V Altomonte, Mary S. Leffell, Richard J. Jones, Paul V. O’Donnell, Ephraim J. Fuchs, Leo Luznik, Mitch A. Phelps, Kenneth H. Cowan, S Piantadosi and Bijoyesh Mookerjee and has published in prestigious journals such as Journal of Clinical Oncology, Blood and International Journal of Radiation Oncology*Biology*Physics.

In The Last Decade

G. B. Vogelsang

28 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. B. Vogelsang United States 17 963 405 267 186 160 28 1.2k
NH Russell United Kingdom 18 975 1.0× 330 0.8× 401 1.5× 262 1.4× 133 0.8× 32 1.2k
A. H. Filipovich United States 17 851 0.9× 561 1.4× 224 0.8× 142 0.8× 110 0.7× 35 1.5k
Mats Remberger Sweden 18 583 0.6× 247 0.6× 398 1.5× 145 0.8× 132 0.8× 37 1.1k
Karin Kolbe Germany 22 759 0.8× 279 0.7× 465 1.7× 146 0.8× 202 1.3× 53 1.2k
J. Gajewski United States 14 687 0.7× 399 1.0× 273 1.0× 130 0.7× 84 0.5× 17 1.0k
WE Beschorner United States 11 819 0.9× 317 0.8× 206 0.8× 101 0.5× 116 0.7× 13 998
J Cahn France 22 1.2k 1.2× 330 0.8× 392 1.5× 216 1.2× 364 2.3× 70 1.6k
Daniel Stachel Germany 15 487 0.5× 372 0.9× 226 0.8× 123 0.7× 158 1.0× 45 1.1k
Axel A. Fauser Germany 15 643 0.7× 240 0.6× 264 1.0× 103 0.6× 180 1.1× 27 978
Monzr M. Al Malki United States 18 761 0.8× 313 0.8× 322 1.2× 192 1.0× 217 1.4× 113 1.2k

Countries citing papers authored by G. B. Vogelsang

Since Specialization
Citations

This map shows the geographic impact of G. B. Vogelsang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. B. Vogelsang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. B. Vogelsang more than expected).

Fields of papers citing papers by G. B. Vogelsang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. B. Vogelsang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. B. Vogelsang. The network helps show where G. B. Vogelsang may publish in the future.

Co-authorship network of co-authors of G. B. Vogelsang

This figure shows the co-authorship network connecting the top 25 collaborators of G. B. Vogelsang. A scholar is included among the top collaborators of G. B. Vogelsang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. B. Vogelsang. G. B. Vogelsang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Arora, Madan L., Joseph Pidala, Corey Cutler, et al.. (2012). Impact of prior acute GVHD on chronic GVHD outcomes: a chronic graft versus host disease consortium study. Leukemia. 27(5). 1196–1201. 16 indexed citations
2.
Pavletic, Steven Z., S J Lee, Gèrard Socié, & G. B. Vogelsang. (2006). Chronic graft-versus-host disease: implications of the National Institutes of Health consensus development project on criteria for clinical trials. Bone Marrow Transplantation. 38(10). 645–651. 73 indexed citations
3.
Richardson, Paul G., Robert J. Soiffer, Joseph H. Antin, et al.. (2006). Defibrotide (DF) for the Treatment of Severe Veno-Occlusive Disease (sVOD) and Multi-Organ Failure (MOF) Post SCT: Final Results of a Multi-Center, Randomized, Dose-Finding Trial.. Blood. 108(11). 43–43. 6 indexed citations
4.
Wolff, Daniel, et al.. (2004). Oral PUVA and topical steroids for treatment of oral manifestations of chronic graft‐vs.‐host disease. Photodermatology Photoimmunology & Photomedicine. 20(4). 184–190. 35 indexed citations
5.
O’Donnell, Paul V., Leo Luznik, Richard J. Jones, et al.. (2002). Nonmyeloablative bone marrow transplantation from partially HLA-mismatched related donors using posttransplantation cyclophosphamide. Biology of Blood and Marrow Transplantation. 8(7). 377–386. 324 indexed citations
6.
Vogelsang, G. B., Bert Myers, Lee F. Rogers, et al.. (2001). Using point-of-care CD34 enumeration to optimize PBSC collection conditions. Cytotherapy. 3(1). 11–18. 11 indexed citations
7.
Leffell, Mary S., et al.. (2001). Association between TGF-β expression and severe GVHD in allogeneic bone marrow transplantation. Transplantation Proceedings. 33(1-2). 485–486. 21 indexed citations
8.
Mookerjee, Bijoyesh, V Altomonte, & G. B. Vogelsang. (1999). Salvage therapy for refractory chronic graft-versus-host disease with mycophenolate mofetil and tacrolimus. Bone Marrow Transplantation. 24(5). 517–520. 85 indexed citations
9.
Marcellus, Deborah, et al.. (1999). Etretinate Therapy for Refractory Sclerodermatous Chronic Graft-Versus-Host Disease. Blood. 93(1). 66–70. 58 indexed citations
10.
Noga, Stephen J., Adriana Seber, Janice M. Davis, et al.. (1998). CD34 Augmentation Improves Allogeneic T Cell-Depleted Bone Marrow Engraftment. Journal of Hematotherapy. 7(2). 151–157. 16 indexed citations
11.
Vogelsang, G. B., et al.. (1997). Human herpes virus-6 encephalitis after bone marrow transplantation: successful treatment with ganciclovir. Bone Marrow Transplantation. 20(10). 905–906. 64 indexed citations
12.
Noga, Stephen J., G. B. Vogelsang, Adriana Seber, et al.. (1997). CD34+ stem cell augmentation of allogeneic, elutriated marrow grafts improves engraftment but cyclosporine a is still required to reduce gvhd and morbidity. Transplantation Proceedings. 29(1-2). 728–732. 8 indexed citations
13.
Miller, Carole B., Steven Piantadosi, G. B. Vogelsang, et al.. (1996). Impact of age on outcome of patients with cancer undergoing autologous bone marrow transplant.. Journal of Clinical Oncology. 14(4). 1327–1332. 50 indexed citations
14.
Vogelsang, G. B., V Altomonte, Evan R. Farmer, et al.. (1996). Treatment of chronic graft-versus-host disease with ultraviolet irradiation and psoralen (PUVA).. PubMed. 17(6). 1061–7. 94 indexed citations
15.
Wagner, John E., G. B. Vogelsang, Barbara A. Zehnbauer, et al.. (1992). Relapse of leukemia after bone marrow transplantation: effect of second myeloablative therapy.. PubMed. 9(3). 205–9. 34 indexed citations
16.
Wagner, John E., S. D. Rowley, John M. Davis, et al.. (1990). Using elutriation to engineer bone marrow allografts.. PubMed. 333. 345–59; discussion 360. 4 indexed citations
17.
Chen, Tianling, G. B. Vogelsang, Brent G. Petty, et al.. (1989). Plasma pharmacokinetics and urinary excretion of thalidomide after oral dosing in healthy male volunteers.. Drug Metabolism and Disposition. 17(4). 402–405. 101 indexed citations
18.
Herman, James G., William E. Beschorner, Kenneth L. Baughman, et al.. (1988). PSEUDO-GRAFT-VERSUS-HOST DISEASE IN HEART AND HEART-LUNG RECIPIENTS. Transplantation. 46(1). 93–97. 10 indexed citations
19.
Santos, G. W., Rein Saral, William H. Burns, et al.. (1987). Allogeneic, Syngeneic and Autologous Marrow Transplantation in the Acute Leukemias and Lymphomas – Baltimore Experiences. Acta Haematologica. 78(1). 175–180. 12 indexed citations
20.
Vogelsang, G. B., et al.. (1986). Thalidomide, a potent agent for the treatment of graft-versus-host disease. 18(4). 904–906. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by NH Russell Breakdown of academic impact, for papers by A. H. Filipovich Breakdown of academic impact, for papers by Mats Remberger Breakdown of academic impact, for papers by Karin Kolbe Breakdown of academic impact, for papers by J. Gajewski Breakdown of academic impact, for papers by WE Beschorner Breakdown of academic impact, for papers by J Cahn Breakdown of academic impact, for papers by Daniel Stachel Breakdown of academic impact, for papers by Axel A. Fauser Breakdown of academic impact, for papers by Monzr M. Al Malki
Rankless by CCL
2026